| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 33.74B | 33.35B | 31.95B | 28.48B | 26.32B | 24.65B |
| Gross Profit | 9.73B | 9.35B | 8.62B | 7.78B | 7.64B | 6.70B |
| EBITDA | 4.49B | 4.29B | 3.78B | 3.33B | 3.48B | 3.01B |
| Net Income | 2.48B | 2.35B | 1.98B | 1.81B | 1.94B | 1.63B |
Balance Sheet | ||||||
| Total Assets | 45.65B | 46.41B | 50.13B | 45.12B | 43.25B | 39.89B |
| Cash, Cash Equivalents and Short-Term Investments | 9.50B | 8.44B | 11.94B | 11.12B | 13.78B | 10.95B |
| Total Debt | 1.17B | 416.00M | 416.00M | 416.00M | 416.00M | 416.25M |
| Total Liabilities | 15.33B | 15.61B | 19.58B | 16.71B | 15.93B | 14.37B |
| Stockholders Equity | 30.31B | 30.79B | 30.55B | 28.41B | 27.32B | 25.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.87B | 1.52B | -1.93B | 3.40B | 3.87B |
| Operating Cash Flow | 0.00 | 541.00M | 3.71B | 1.33B | 3.63B | 4.30B |
| Investing Cash Flow | 0.00 | -3.06B | -2.21B | -3.28B | -240.00M | -445.62M |
| Financing Cash Flow | 0.00 | -976.00M | -640.00M | -717.00M | -558.00M | -536.43M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥73.81B | 9.50 | ― | 2.63% | -6.00% | -13.74% | |
75 Outperform | ¥43.67B | 11.30 | ― | 3.00% | 12.75% | 96.71% | |
75 Outperform | ¥64.55B | 13.24 | ― | 3.95% | -1.67% | -4.39% | |
74 Outperform | ¥63.21B | 24.26 | ― | 2.54% | 2.00% | 39.80% | |
70 Outperform | ¥64.89B | 4.09 | ― | 3.09% | 6.35% | -34.20% | |
69 Neutral | ¥74.81B | 10.78 | 7.00% | 3.02% | 15.78% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |